Evidence map›Paper›PMID 37057290›Full record

ArticleJournal of Cancer2023

A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK/AP-1 axis and dephosphorylation of EPHA2.

Shu Lei, Xiangjun He, Xiao Yang, Xuan Gu, Yijiao He, Jianliu Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. The Role of Redox Environment in Tumors.Current medicinal chemistry · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shu LeiDepartment of Gynecology and Obstetrics, Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing 100044, China.
Xiangjun HeDepartment of Gynecology and Obstetrics, Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing 100044, China.
Xiao YangDepartment of Gynecology and Obstetrics, Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing 100044, China.
Xuan GuDepartment of Gynecology and Obstetrics, Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing 100044, China.
Yijiao HeDepartment of Gynecology and Obstetrics, Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing 100044, China.
Jianliu WangDepartment of Gynecology and Obstetrics, Central Laboratory & Institute of Clinical Molecular Biology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing 100044, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AP-1 complexDUSP1Endometrial carcinomaEPHA2.MAPK pathway

Identifiers

PMID37057290
PMCPMC10088542
OpenAlexW4324009741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.